Injection drug use limits benefits of surgery for treatment of heart lining infection

Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1JzWwe4